Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review by Lauro Fabián Amador-Medina, Erick Crespo-Solís, Francisco Javier Turrubiates-Hernández, Karla Edith Santibañez-Bedolla

Get full text

Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses by Diana Lourdes Padilla-Bórquez, Mónica Guadalupe Matuz-Flores, Jorge Hernández-Bello, Jesús Alfredo Rosas-Rodríguez, Francisco Javier Turrubiates-Hernández, Samuel García-Arellano, Guillermo González-Estevez, Hazael Ramiro Ceja-Galvez, Edith Oregon-Romero, Alberto López-Reyes, Jose Francisco Muñoz-Valle

Get full text

Survival analysis of adult patients with ALL in Mexico City: first report from the Acute Leukemia Workgroup (ALWG) (GTLA) by Erick Crespo‐Solis, Karla Espinosa‐Bautista, Martha Alvarado‐Ibarra, Etta Rozen‐Fuller, Fernando Pérez‐Rocha, Chantal Nava‐Gómez, Maricela Ortiz‐Zepeda, José Luis Álvarez‐Vera, Christian Omar Ramos‐Peñafiel, Luis Antonio Meillón‐García, Sergio Rodríguez‐Rodríguez, Alan Pomerantz‐Okon, Francisco Javier Turrubiates‐Hernández, Roberta Demichelis‐Gómez

Get full text